Insider Transactions in Q1 2025 at Intuitive Surgical Inc (ISRG)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
489
-18.95%
|
$260,637
$533.18 P/Share
|
|
Mar 06
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
492
-16.02%
|
$274,536
$558.95 P/Share
|
|
Mar 05
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
492
-13.8%
|
$272,568
$554.17 P/Share
|
|
Mar 05
2025
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
16,509
-3.49%
|
$9,195,513
$557.52 P/Share
|
|
Mar 05
2025
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
29,250
+5.81%
|
$1,989,000
$68.23 P/Share
|
|
Mar 04
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
492
-12.13%
|
$276,996
$563.69 P/Share
|
|
Mar 03
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
492
-10.82%
|
$281,916
$573.78 P/Share
|
|
Mar 03
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,031
-89.57%
|
$1,748,887
$577.3 P/Share
|
|
Mar 03
2025
|
Fredrik Widman VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
810
-63.13%
|
$464,130
$573.78 P/Share
|
|
Feb 28
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Payment of exercise price or tax liability
|
Direct |
2,610
-19.21%
|
$1,469,430
$563.77 P/Share
|
|
Feb 28
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
BUY
Exercise of conversion of derivative security
|
Direct |
877
+10.91%
|
-
|
|
Feb 28
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,983
-25.08%
|
$1,679,429
$563.77 P/Share
|
|
Feb 28
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,002
+13.6%
|
-
|
|
Feb 28
2025
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
233
-15.37%
|
$131,179
$563.77 P/Share
|
|
Feb 28
2025
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
468
+23.59%
|
-
|
|
Feb 28
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
3,553
-10.74%
|
$2,000,339
$563.77 P/Share
|
|
Feb 28
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,504
+8.11%
|
-
|
|
Feb 28
2025
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Open market or private sale
|
Direct |
188
-1.3%
|
$106,408
$566.94 P/Share
|
|
Feb 28
2025
|
Jamie Samath EVP & CFO & Enterprise Technol |
BUY
Exercise of conversion of derivative security
|
Direct |
940
+3.32%
|
$156,040
$166.41 P/Share
|
|
Feb 28
2025
|
Jamie Samath EVP & CFO & Enterprise Technol |
SELL
Payment of exercise price or tax liability
|
Direct |
2,238
-12.31%
|
$1,259,994
$563.77 P/Share
|
|
Feb 28
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
2,020
-10.6%
|
$1,137,260
$563.77 P/Share
|
|
Feb 28
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
752
+7.12%
|
-
|
|
Feb 28
2025
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,456
-19.02%
|
$4,197,728
$563.77 P/Share
|
|
Feb 28
2025
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,506
+10.83%
|
-
|
|
Feb 28
2025
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,475
-1.0%
|
$2,519,425
$563.77 P/Share
|
|
Feb 28
2025
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,504
+0.67%
|
-
|
|
Feb 28
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,358
-10.69%
|
$1,890,554
$563.77 P/Share
|
|
Feb 28
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,128
+6.52%
|
-
|
|
Feb 27
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
BUY
Grant, award, or other acquisition
|
Direct |
4,385
+41.11%
|
-
|
|
Feb 27
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,012
+39.22%
|
-
|
|
Feb 27
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Grant, award, or other acquisition
|
Direct |
7,518
+32.61%
|
-
|
|
Feb 27
2025
|
Jamie Samath EVP & CFO & Enterprise Technol |
BUY
Grant, award, or other acquisition
|
Direct |
3,758
+30.29%
|
-
|
|
Feb 27
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
BUY
Grant, award, or other acquisition
|
Direct |
3,758
+29.33%
|
-
|
|
Feb 27
2025
|
Gary S Guthart CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,530
+40.86%
|
-
|
|
Feb 27
2025
|
David J. Rosa President |
BUY
Grant, award, or other acquisition
|
Direct |
7,518
+3.27%
|
-
|
|
Feb 27
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,638
+27.25%
|
-
|
|
Feb 27
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,401
-87.18%
|
$1,394,981
$581.0 P/Share
|
|
Feb 26
2025
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,740
-0.64%
|
$1,570,020
$573.74 P/Share
|
|
Feb 26
2025
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,526
+1.26%
|
-
|
|
Feb 26
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
1,343
-12.06%
|
$769,539
$573.74 P/Share
|
|
Feb 26
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
2,998
+21.09%
|
-
|
|
Feb 26
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Payment of exercise price or tax liability
|
Direct |
1,229
-26.87%
|
$704,217
$573.74 P/Share
|
|
Feb 26
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
BUY
Exercise of conversion of derivative security
|
Direct |
2,477
+34.3%
|
-
|
|
Feb 26
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,622
-8.28%
|
$929,406
$573.74 P/Share
|
|
Feb 26
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,269
+14.29%
|
-
|
|
Feb 26
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,362
-38.29%
|
$1,353,426
$573.74 P/Share
|
|
Feb 26
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,763
+43.51%
|
-
|
|
Feb 26
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
1,226
-7.54%
|
$702,498
$573.74 P/Share
|
|
Feb 26
2025
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
3,114
+16.05%
|
-
|
|
Feb 26
2025
|
Gary Loeb EVP & Chief Legal and Complian |
SELL
Payment of exercise price or tax liability
|
Direct |
758
-16.12%
|
$434,334
$573.74 P/Share
|